Hepa-Merz

Medicinal product

(Invented) name

Hepa-Merz

Active substance (s)

L-ornitino L-aspartatas

Strength

3000 mg

Pharmaceutical form

granulės geriamajam tirpalui

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A05BA, Liver therapy

Marketing authorisation holder

Merz Pharmaceuticals GmbH, Vokietija

Date of authorisation

1994-06-02

Date of renewal

2014-01-31

Documents

0572 Pakuotės lapelis 2025 07 13.docx

0572 Hepa_Merz PCS PL 2025 07 13.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Viename 5 g paketėlyje yra	1 vnt.
L-ornitino L-aspartatas	3000 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
18057	21784	1021784	paketėlis	5 g N30		Receptinis	LT/1/94/0572/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2014-01-31	Perregistruotas
1994-06-02	Registruotas